{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicpacel2ktf7mwsuffppbc54non23sdya7kqzg26rulgs3jerio4m",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3ml24cwefcd42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigqz4ph5w5xxnaigdq3cnnvb2aw27f327rk7zqrb4u4y6gkoaxs3a"
    },
    "mimeType": "image/jpeg",
    "size": 73549
  },
  "path": "/2026/05/04/biotech-startup-latus-bio-raises-42-million-run-huntingtons-trial/?utm_campaign=rss",
  "publishedAt": "2026-05-04T11:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Exclusive",
    "biotechnology",
    "Gene therapy",
    "rare diseases",
    "Startups",
    "STAT+"
  ],
  "textContent": "Latus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for Huntington's disease.",
  "title": "STAT+: Biotech raises $42 million to run Huntington’s disease trial",
  "updatedAt": "2026-05-03T22:46:58.000Z"
}